Skip to content
FrontierPicks

Dormant

MKSI · MKS Inc.

Conviction · LOW Cyclical recovery Catalyst · Semi foundry & equipmentAI datacenter infrastructure

Last analysed ·

Resolved Graded and closed 2026-08-21 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.

Current thesis

Operating leg accelerating into a de-rating tape: Q2 (2026-08-05) beat at $1.248B revenue / $3.30 adj EPS, Q3 guide $1.310–1.390B tops the $1.243B Street, leverage down to 3.0x — and the stock still fell 4.49% on the print and sits 31.4% below the $444.80 high. Picks-and-shovels narrative now saturated, with no company binary until the ~November Q3 print.

Kill line

A weekly close below $280 (decisively beneath the May shelf the July round-trip returned to); secondarily, Q3 revenue under the $1.310B guide floor, or net leverage stalling at or above 3.0x at the Q3 print.

Pick status

Invalidated resolved published kill line fired How this is scored →

Latest analysis and events for MKSI —

As of 13 September 2026, the latest FrontierPicks analysis for MKS Inc. (MKSI): Operating leg accelerating into a de-rating tape: Q2 (2026-08-05) beat at $1.248B revenue / $3.30 adj EPS, Q3 guide $1.310–1.390B tops the $1.243B Street, leverage down to 3.0x — and the stock still fell 4.49% on the print and sits 31.4% below the $444.80 high. Picks-and-shovels narrative now saturated, with no company binary until the ~November Q3 print.

Kill line: A weekly close below $280 (decisively beneath the May shelf the July round-trip returned to); secondarily, Q3 revenue under the $1.310B guide floor, or net leverage stalling at or above 3.0x at the Q3 print.

Next dated event on file: — catalyst in 10d.

Current Thesis

MKS Inc.'s semiconductor and packaging growth supports a tentative recovery thesis: a weekly close above the former $280 shelf would establish initial price repair, while a weekly close below $255.76 would end that case. The operating evidence remains the company's 2026-08-05 report: second-quarter revenue of $1.248 billion and third-quarter revenue guidance of $1.310–1.390 billion. MKS results release.

The earlier continuation thesis already failed when the adjusted weekly close reached $279.11 on 2026-08-21, below its published $280 condition. The original narrative is dead in price terms — that breach remained unrepaired at the 2026-09-11 adjusted close of $267.31. This is an interpretation of the published price condition, not evidence that operating demand has collapsed.

The narrower recovery case is a new, low-conviction forecast; it does not reverse the earlier invalidation. Its defined outcome is a weekly close above $280 before a weekly close below $255.76, the market's 2026-08-28 reference close.

Bullish and bearish views on MKS Inc.

The model's bull view on MKS Inc. (MKSI), in brief: Operating results support the story. MKS reported second-quarter adjusted diluted earnings per share of $3.30 and an adjusted operating margin of 25.6% on 2026-08-05. These measurements support the earnings component of the recovery hypothesis; they do not establish renewed… The bear view: The former shelf remains unrecovered. The 2026-09-11 adjusted close of $267.31 remained below the previously published $280 structural threshold. The old continuation case therefore remains invalidated despite the higher latest close. Medium-term price damage persists. As of… Both cases follow in full.

Bull Case

  • Operating results support the story. MKS reported second-quarter adjusted diluted earnings per share of $3.30 and an adjusted operating margin of 25.6% on 2026-08-05. These measurements support the earnings component of the recovery hypothesis; they do not establish renewed market demand for the shares. MKS results release.
  • Debt reduction has concrete evidence. The 2026-08-05 release disclosed an August voluntary term-loan principal prepayment of $100 million. This is observable debt reduction supporting the financial component of the case. MKS results release.
  • The latest close is higher. The adjusted close was $267.31 on 2026-09-11 versus $255.76 on 2026-08-28. That establishes improvement between the dated observations; the sample is too small to establish a durable reversal.

Bear Case

  • The former shelf remains unrecovered. The 2026-09-11 adjusted close of $267.31 remained below the previously published $280 structural threshold. The old continuation case therefore remains invalidated despite the higher latest close.
  • Medium-term price damage persists. As of 2026-09-11, the adjusted series showed a three-month price decline of 24.8% and a close 39.8% below its $444.39 trailing-year high. These are measured price conditions, not a valuation conclusion.
  • Analyst optimism has qualified support. Mizuho maintained its Outperform rating but reduced its price target from $360 to $330 on 2026-08-25, according to Benzinga. That is a dated reduction in one firm's valuation expectation; it does not establish a continuing sequence of cuts. Benzinga analyst actions.

Setup & Price Structure

The 2026-09-11 adjusted reference close of $267.31 lies between the 2026-08-28 close of $255.76 and the former $280 shelf identified in the 2026-08-30 coverage. These are the recovery hypothesis's lower boundary and confirmation level, respectively. Neither is an independently verified current moving average or an intraday low.

The 14-day relative strength index (RSI) was 42.4 on 2026-09-11. Moving-average levels, turnover and current short-interest measurements are unavailable in the supplied price evidence, so participation and crowding cannot be quantified.

Public attention is observable: Zacks published a favorable growth-stock article on 2026-09-01, followed by the supplied 2026-09-11 historical-return headline. This small coverage sample supports no claim that retail participation is expanding or exhausted. Zacks article.

Catalyst Calendar (next 30 days)

  • 2026-09-30 — Micron fiscal fourth-quarter results. Micron's 2026-08-26 announcement schedules its conference call for 2:30 p.m. Mountain time. Its discussion of memory demand and investment can test the sector backdrop, but cannot establish MKS's own orders or revenue. Micron announcement.

As checked on 2026-09-13, MKS's investor calendar listed no upcoming event. Its next earnings date is therefore unconfirmed; no estimated November date is treated as a scheduled catalyst. MKS event calendar.

What Would Change Our Mind

Loss of the market's 2026-08-28 reference close would end the tentative recovery case: a weekly close below $255.76 is the published thesis-break condition. A weekly close above the former $280 shelf before that breach would satisfy the limited price-repair case. It would not retroactively validate the continuation thesis that failed on 2026-08-21.

Operating confirmation remains separate. Third-quarter revenue below the $1.310 billion lower boundary of guidance issued on 2026-08-05 would contradict the revenue premise supporting recovery. The reporting date remains unconfirmed. MKS results release.

Correlation Notes

This is assessed as a single-name recovery setup. MKS's 2026-08-05 release identifies semiconductor manufacturing and electronics packaging among its end markets, which supports a semiconductor-equipment exposure classification. MKS results release.

Micron's confirmed 2026-09-30 report supplies an external demand checkpoint. A direct read-through to MKS revenue is an inference that would require subsequent MKS disclosures to confirm; no measured return correlation or customer-order linkage is available here. Micron announcement.

Notes

  • Levered cyclical: net leverage 3.0x as of the Q2 2026 call against a stated 2-2.5x target; the quarterly leverage line is structural to the EPS story.
  • Reporting dates have drifted later — Q2 2026 landed 2026-08-05 after the close with the call 2026-08-06. Each quarter's date is worth verifying from IR.
  • Company is MKS Inc. (Nasdaq: MKSI); legacy news feeds still headline it as MKS Instruments. Same issuer.
  • Part of the capital structure is euro-denominated after the EUR 1.0B note offering of February 2026, so EUR/USD affects reported leverage.
  • Insider sales run through pre-planned 10b5-1 programs; the 2026-05-22 executions at $315.48 sit well above the 2026-08-28 close, with no offsetting insider buying disclosed.

Related · shared themes

See also · stocks to watch